Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Universal choose IVS
IVS
Bankrupt
CVR 36721375
Højagerparken 33, 1. tv
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2015
2 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2018
DKK 382K
+8% vs 2017
EBITDA margin
22.2%
+1825% vs 2017
Equity ratio
57.6%
Financial strength
Net profit 2018
DKK 64K
+419% vs 2017
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2016
0M
0%
2017
0M
0%
2018
Key figures
Annual report 2018
Revenue
DKK 382K
+8%
EBITDA
DKK 85K
+1825%
Net profit
DKK 64K
+419%
Total assets
DKK 171K
-16%
Equity
DKK 98K
+189%
Employees
2
—
Company information
Legal name
Universal choose IVS
CVR number
36721375
Legal form
Iværksætterselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
22. april 2015
Share capital
DKK 500
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2018-09-30
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Contact
Address
Højagerparken 33, 1. tv
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Ballerup
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2016
0M
2017
0M
2018
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2016
0M
2017
0M
2018
Income statement
DKK thousands
Item
2016
2017
2018
Revenue
240
356
382
Staff expenses
-171
-361
-297
EBITDA
69
-5
85
Depreciation & amort.
-0
-0
-0
EBIT
69
-5
85
Net financials
-0
-1
-3
Profit before tax
69
-6
82
Tax
15
14
18
Net profit
54
-20
64
Balance sheet
DKK thousands
Item
2016
2017
2018
Total assets
204
202
171
Equity
54
34
98
Long-term debt
15
0
0
Short-term debt
135
168
72
Total debt
150
168
72
Financial ratios
5-year trend
EBITDA margin
22.2%
This company
15.8%
Market median
+41% vs market
2016
2018
Equity ratio
57.6%
This company
38.2%
Market median
+51% vs market
2016
2018
Return on equity
65.4%
This company
18.4%
Market median
+255% vs market
2016
2018
Net profit margin
16.8%
This company
8.1%
Market median
+107% vs market
2016
2018
Asset turnover
2.24×
This company
1.12×
Market median
+100% vs market
2016
2018
Debt / equity
0.74×
This company
0.62×
Market median
+19% vs market
2016
2018
Annual reports & filings
Annual report 2018
Filed via CVR / Virk · Period 2017-10-01 – 2018-09-30
View
PDF
Annual report 2017
Filed via CVR / Virk · Period 2016-10-01 – 2017-09-30
View
PDF
Annual report 2016
Filed via CVR / Virk · Period 2015-04-22 – 2016-09-30
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
BL
Bo Lauritzen
Unofficial title
Unofficial title
2020
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Gazi Mermer
Individual
100.0%
100.0%
2015
Alan Akram Karem
Individual
100.0%
100.0%
2019
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Universal choose IVS also hold positions in
0
other companies.
Person
Role here
Other companies
Bo Lauritzen
Unofficial title
0 companies